多模态磁共振成像评估急性缺血性卒中缺血半暗带的研究进展

doi:10.3969/j.issn.1673-5765.2019.08.019

摘要/Abstract

摘要：

急性缺血性卒中（acute ischemic stroke，AIS）的缺血半暗带（ischemic penumbra，IP）一直是急性血管内介入治疗中影像评估关注的重点和热点问题。由于多模态MRI可以提供丰富的病理生理学参数，在IP临床评估中具有良好前景。本文对各类MRI成像策略对于IP评估的特点与局限进行介绍，重点介绍了新型技术酰胺质子转移成像（amide proton transfer，APT）。APT通过对脑缺血区域细胞内pH 值的精确判断，能够准确评估IP。虽然目前APT临床应用尚少，但随着其成像技术的不断改进，有望成为辅助决策AIS患者治疗的重要影像学检查手段。

文章导读： 本文介绍了缺血半暗带评估在急性缺血性卒中治疗决策中的意义，比较了各类MRI策略对于缺血半暗带评估的优劣，其中新型技术酰胺质子转移成像对于指导急性缺血性卒中患者的治疗方式与预后预测具有很大的潜力。

关键词: 缺血性卒中; 磁共振成像; 酰胺质子转移成像; 缺血半暗带

Abstract:

Ischemic penumbra (IP) in acute ischemic stroke (AIS) has always been the focus of imaging evaluation in acute endovascular treatment. Because multimodal MRI can provide many pathophysiological parameters, using multimodal MRI to evaluate IP is promising. This article introduced the characteristics and limitation of different MRI sequence for assessing IP, with emphasis on the new technology amide proton transfer (APT) imaging, which can properly evaluate IP through accurate determination of intracellular pH value in cerebral ischemia region. Although APT is rarely used in clinical examination at present, it is believed that APT will become an important imaging technique for the diagnosis and treatment of AIS patients in the future, with the improvement of imaging technology.

Key words: Ischemic stroke; Magnetic resonance imaging; Amide proton transfer imaging;Ischemic penumbra

何浩然，俎中良，刘勇. 多模态磁共振成像评估急性缺血性卒中缺血半暗带的研究进展[J]. 中国卒中杂志, 2019, 14(08): 842-847.

HE Hao-Ran, ZU Zhong-Liang, LIU Yong. Advance in Detection of Ischemic Penumbra in Acute Ischemic Stroke Using Multimodal Magnetic Resonance Imaging[J]. Chinese Journal of Stroke, 2019, 14(08): 842-847.

参考文献

[1] BADHIWALA J H，NASSIRI F，ALHAZZANI W，

et al. Endovascular thrombectomy for acute ischemic

stroke：a Meta-analysis[J]. JAMA，2015，314（17）：

1832-1843.

[2] ASTRUP J，SIESJO B K，SYMON L. Thresholds in

cerebral ischemia - the ischemic penumbra[J]. Stroke，

1981，12（6）：723-725.

[3] LEIGH R，KNUTSSON L，ZHOU J，et al. Imaging

the physiological evolution of the ischemic penumbra

in acute ischemic stroke[J]. J Cereb Blood Flow

Metab，2017，38（9）：1500-1516.

[4] HOSSMANN K A. Viability thresholds and the

penumbra of focal ischemia[J]. Ann Neurol，1994，36

（4）：557-565.

[5] HEISS W D. Ischemic penumbra：evidence from

functional imaging in man[J]. J Cereb Blood Flow

Metab，2000，20（9）：1276-1293.

[6] ALBERS G W，MARKS M P，KEMP S，et al.

Thrombectomy for stroke at 6 to 16 hours with

selection by perfusion imaging[J]. N Engl J Med，

2018，378（8）：708-718.

[7] SAPOSNIK G，STRBIAN D. Correction to：

enlightenment and challenges offered by DAWN

trial（DWI or CTP Assessment With Clinical

Mismatch in the Triage of Wake Up and Late

Presenting Strokes Undergoing Neurointervention

With Trevo）[J/OL]. Stroke，2018，49（2）：e38.

https：//www.ahajournals.org/doi/10.1161/STR.

0000000000000162.

[8] LOGOTHETIS N K. What we can do and what we

cannot do with fMRI[J]. Nature，2008，453（7197）：

869-878.

[9] BRODERICK J P，PALESCH Y Y，DEMCHUK A

M，et al. Endovascular therapy after intravenous t-PA

versus t-PA alone for stroke[J]. N Engl J Med，2013，

368（10）：893-903.

[10] BARON J C. Mapping the ischaemic penumbra with

PET：a new approach[J]. Brain，2001，124（1）：2-4.

[11] ZHU G，JOVIN T，AGHAEBRAHIM A，et al.

Does perfusion imaging add value compared with plain parenchymal and vascular imaging?[J]. J

Neurointerv Surg，2012，4（4）：246-250.

[12] VILLRINGER A，ROSEN B R，BELLIVEAU J W，

et al. Dynamic imaging with lanthanide chelates in

normal brain：contrast due to magnetic susceptibility

effects[J]. Magn Reson Med，1988，6（2）：164-174.

[13] ALBERS G W，THIJS V N，WECHSLER L，et

al. Magnetic resonance imaging profiles predict

clinical response to early reperfusion：the diffusion

and perfusion imaging evaluation for understanding

stroke evolution（DEFUSE）study[J]. Ann Neurol，

2006，60（5）：508-517.

[14] DAVIS S M，DONNAN G A，PARSONS M W，et

al. Effects of alteplase beyond 3 h after stroke in

the Echoplanar Imaging Thrombolytic Evaluation

Trial（EPITHET）：a placebo-controlled randomised

trial[J]. Lancet Neurol，2008，7（4）：299-309.

[15] LANSBERG M G，LEE J，CHRISTENSEN S，et al.

RAPID automated patient selection for reperfusion

therapy：a pooled analysis of the Echoplanar Imaging

Thrombolytic Evaluation Trial（EPITHET）and the

Diffusion and Perfusion Imaging Evaluation for

Understanding Stroke Evolution（DEFUSE）study[J].

Stroke，2011，42（6）：1608-1614.

[16] KIDWELL C S，JAHAN R，GORNBEIN J，et al. A

trial of imaging selection and endovascular treatment

for ischemic stroke[J]. N Engl J Med，2013，368（10）：

914-923.

[17] BERKHEMER O A，FRANSEN P S，BEUMER D，

et al. A randomized trial of intraarterial treatment

for acute ischemic stroke[J]. N Engl J Med，2015，372

（1）：11-20.

[18] SAVER J L，GOYAL M，BONAFE A，et al. Stentretriever

thrombectomy after intravenous t-PA vs.

t-PA alone in stroke[J]. N Engl J Med，2015，372

（24）：2285-2295.

[19] LEGRAND L，TISSERAND M，TURC G，et

al. Fluid-attenuated inversion recovery vascular

hyperintensities-diffusion-weighted imaging

mismatch identifies acute stroke patients most likely

to benefit from recanalization[J]. Stroke，2016，47

（2）：424-427.

[20] ZHOU J，PAYEN J F，WILSON D A，et al. Using

the amide proton signals of intracellular proteins and

peptides to detect pH effects in MRI[J]. Nat Med，

2003，9（8）：1085-1090.

[21] ZHOU J，VAN ZIJI P C. Defining an acidosis-based

ischemic penumbra from ph-weighted MRI[J]. Transl

Stroke Res，2011，3（1）：76-83.

[22] ZHANG X Y，WANG F，AFZAL A，et al. A new

NOE-mediated MT signal at around -1.6 ppm for

detecting ischemic stroke in rat brain[J]. Magn

Reson Imaging，2016，34（8）：1100-1106.

[23] SUN P Z，ZHOU J，SUN W，et al. Detection of the

ischemic penumbra using pH-weighted MRI[J]. J

Cereb Blood Flow Metab，2007，27（6）：1129-1136.

[24] CAI K，HARIS M，SINGH A，et al. Magnetic

resonance imaging of glutamate[J]. Nat Med，2012，

18（2）：302-306.

[25] JIN T，WANG P，HITCHENS T K，et al. Enhancing

sensitivity of pH-weighted MRI with combination of

amide and guanidyl CEST[J]. Neuroimage，2017，157

（1）：341-350.

[26] TEE Y K，HARSTON G W，BLOCKLEY N，et

al. Comparing different analysis methods for

quantifying the MRI amide proton transfer（APT）

effect in hyperacute stroke patients[J]. NMR Biomed，

2014，27（9）：1019-1029.

[27] TIETZE A，BLICHER J，MIKKELSEN I K，et

al. Assessment of ischemic penumbra in patients

with hyperacute stroke using amide proton transfer

（APT）chemical exchange saturation transfer（CEST）

MRI[J]. NMR Biomed，2014，27（2）：163-174.

[28] HARSTON G W，TEE Y K，BLOCKLEY N，et

al. Identifying the ischaemic penumbra using pHweighted

magnetic resonance imaging[J]. Brain，

2015，138（Pt1）：36-42.

[29] HEO H Y，ZHANG Y，BURTON T M，et al.

Improving the detection sensitivity of pH-weighted

amide proton transfer MRI in acute stroke patients

using extrapolated semisolid magnetization transfer

reference signals[J]. Magn Reson Med，2017，78（3）：

871-880.

[30] ZHU H，JONES C K，VAN ZIJL P C，et al. Fast

3D chemical exchange saturation transfer（CEST）

imaging of the human brain[J]. Magn Reson Med，

2010，64（3）：638-644.